Americans Turn to Gray Market for DIY Weight-Loss Drugs Amid High Costs

A significant number of Americans are now exploring the gray market for obesity medications due to soaring prescription drug prices. This emerging trend has raised concerns among leading pharmaceutical companies, including Eli Lilly and Novo Nordisk, who warn of the potential dangers and illegality of such practices. This report delves into the motivations behind this shift and the implications for public health and the pharmaceutical industry.